Long‐term results of the treatment of primary hyperhidrosis with oxybutynin: follow‐up of 1,658 cases

Background Hyperhidrosis (HH) is characterized by exaggerated sweating in a specific region due to hyperfunction of the sweat glands. In the late 2000s, we started treating patients with an anticholinergic, oxybutynin, that was not being used until then. Objectives To present, after 12 years of util...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of dermatology 2020-06, Vol.59 (6), p.709-715
Hauptverfasser:	Wolosker, Nelson, Kauffman, Paulo, de Campos, José R. M., Faustino, Carolina B., da Silva, Marcelo F. A., Teivelis, Marcelo P., Puech‐Leão, Pedro
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Adolescent Adult Anticholinergics Axilla Drug Administration Schedule Face Female Follow-Up Studies Hand Humans Hyperhidrosis Hyperhidrosis - diagnosis Hyperhidrosis - drug therapy Hyperhidrosis - psychology Male Mandelic Acids - administration & dosage Mandelic Acids - adverse effects Middle Aged Muscarinic Antagonists - administration & dosage Muscarinic Antagonists - adverse effects Patient Satisfaction - statistics & numerical data Patients Quality of Life Retrospective Studies Severity of Illness Index Surveys and Questionnaires - statistics & numerical data Sweat gland Sweating Time Factors Treatment Outcome Xerophthalmia - chemically induced Xerophthalmia - diagnosis Xerophthalmia - epidemiology Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!